Journal of Ocular Pharmacology and Therapeutics
Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines ophthalmology and pharmacology to enable optimal treatment, prevention, and diagnosis of ocular diseases and disorders. It presents the latest in the ophthalmic drug discovery, delivery, and product development, emphasizing biopharmaceutics, pharmacokinetics, pharmacodynamics, and mechanisms of drug action.
Journal of Ocular Pharmacology and Therapeutics coverage includes:
Drug discovery and development
Mechanisms of drug action
Drug delivery, nanomedicine, and nanotechnology
Biopharmaceutics, pharmacokinetics, pharmacodynamics, and mathematical modeling
Drug transporters and drug metabolism
Pre-clinical and early-stage clinical trial results
Gene and cell-based therapies
Combination products
Ocular pharmacotherapy/clinical trials/biomarkers
Ocular toxicology and toxicokinetics
Dry eye and ocular surface diseases
Corneal diseases
Glaucoma and optic neuropathies
Retinal diseases
Lens and cataract
Ocular infection and trauma
Ocular inflammatory and immune disorders
Ocular ischemia and blood flow
Ocular metabolic disorders
Ocular pain
Oculomotor complications
Proliferative disorders of the eye
Therapeutics for myopia and refractive errors
Therapeutics for strabismus, ambylopia, and visual processing
Eyes on New Product Development — written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA
Journal of Ocular Pharmacology and Therapeutics is under the editorial leadership of Uday B. Kompella, PhD, University of Colorado Anschutz Medical Campus; and his Associate Editors: Linda D. Hazlett, PhD, Wayne State University School of Medicine, Ocular Surface Pharmacology; Naj A. Sharif, PhD, FARVO, Santen Incorporated, Pre-clinical Ocular Pharmacology; Carol B. Toris, PhD, The Ohio State University Wexner Medical Center, Aqueous Humor Dynamics; and Oliver Zeitz, MD, Charité - University Medicine Berlin; and an editorial board of leading experts.
Audience: Academic, industry, and government scientists, ophthalmologists, optometrists, clinical and research trainees, and many others
| Uday B. Kompella, PhD, FARVO, FAAPS | Univ Of Colorado Anschutz Medical Campus, Aurora, CO, USA |
| Linda D Hazlett, FARVO | Wayne State University School of Medicine, Detroit, MI, USA |
| Najam A Sharif, PhD, DSC, FARVO, FAOPT, FBPHS | Nanoscope Therapeutics Inc, Dallas, TX, USA |
| Carol B Toris, PhD | Case Western Reserve University, Cleveland, OH, USA |
| Oliver Zeitz, MD, PhD | Charite Universitatsmedizin Berlin, Berlin, Germany |
| Marc Labetoulle, PhD | University Paris Saclay, New Rochelle, NY, USA |
| Sanjoy K. Bhattacharya | University of Miami, Miami, FL, USA |
| Curtis R Brandt, PhD | Univ Of Wisconsin-Madison, Madison, WI, USA |
| Claudio Bucolo, PhD, FARVO, FAOPT | University of Catania, Catania, Italy |
| Anuj Chauhan, PhD | Colorado School Of Mines, Golden, CO, USA |
| Abbot Abe Clark, PhD | Univ Of North Texas Health Science Center, Fort Worth, TX, USA |
| Vivien Coulson-Thomas, PhD | University of Houston, Houston, TX, USA |
| Cintia De Paiva, FARVO | Baylor College of Medicine, Houston, TX, USA |
| Nicholas A Delamere, FARVO | University Of Arizona, Tuscon, AZ, USA |
| Filippo Drago, FARVO, FAOPT | Univ Of Catania Medical School, Catania, Italy |
| Deepta Ghate | Emory University School of Medicine, Atlanta, GA, USA |
| Brian C Gilger, DVM, MS, DACVO, DABT, FARVO | North Carolina State University, Raleigh, NC, USA |
| David Hinkle, MD | Tulane University, New Orleans, LA, USA |
| Shahid Husain, PhD | Medical University of South Carolina, Charleston, SC, USA |
| Ashwath Jayagopal, FARVO, FAOPT, PhD | F Hoffmann-La Roche Ltd, Basel, Switzerland |
| Achim H Krauss, PhD, FAOPT | Archer Ophthalmics, San Marcos, CA, USA |
| Hyung Keun Lee, MD | Yonsei University College of Medicine, Seoul, South Korea |
| Goldis Malek, FARVO, FAOPT | Duke Eye Center, Durham, NC, USA |
| Alan D Marmorstein, PhD | Mayo Clinic Guggenheim 9, Rochester, MN, USA |
| Dr Rajiv R Mohan | University of Missouri, Columbia, MO, USA |
| Sheryl Nale | Endicott, NY, USA |
| Ron Neumann, FOI, IUSG, AAO, ARVO | Maccabi Health Care Services, Tel Aviv-Yafo, Israel |
| Michael R Niesman, PhD | Mingsight Pharmaceuticals, San Diego, CA, USA |
| Gary D Novack, PhD, DABCP, FACCP | Pharma-Logic Development Inc, San Rafael, CA, USA |
| Sunny E Ohia, PhD, FARVO, FAS | Texas Southern University, Houston, TX, USA |
| Catherine A Opere, FARVO | Creighton University, Omaha, NE, USA |
| Stephen Poor, MD | Novarits Institutes For Biomedical Research, New Rochelle, NY, USA |
| Ganesh Prasanna, PhD, FARVO, FAOPT | Novartis Institutes for BioMedical Research, Cambridge, MA, USA |
| Cheryl Rowe-Rendleman, PhD, FAOPT | Omar Consulting Group Llc, Durham, NC, USA |
| Leopold Schmetterer, PhD | Singapore Eye Research Institute, Singapore, Singapore |
| Sangly P Srinivas, PhD, FARVO | Indiana University, Bloomington, IN, USA |
| Shusheng Wang, FAOPT | Tulane University, New Orleans, LA, USA |
| Heping Xu, MD, PhD, FARVO, FAOPT | Queens University Belfast, Northern Ireland, United Kingdom |
| Thomas Yorio, FARVO, FAOPT | North Texas Univ Hlth Sci Ctr, Fort Worth, TX, USA |
| Craig Crosson, PhD | Storm Eye Institute-Musc, Charleston, SC, USA |
| George C.Y. Chiou, PhD | |
| W Daniel Stamer, PhD | Duke University, Durham, NC, USA |